speb/financial-data huggingface dataset:
Financial ratios for HATHWAY.NS — quarterly report dated 2025-12-31
Total revenue: 59770524.67416732
Gross profit: 27750919.015261225
Operating income: 378745.683413167
Net income: 2418402.5843823105
Capital expenditures: 0
Depreciation & amortization: 8244402.361590732
Owner earnings: 10662804.945973042
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.1384649660242843
P/E ratio: 20.92875444628708
Shares outstanding: 1770104500
Market cap (USD): 245097459.45193273
Effective tax rate (%): 22.959545777146914
Interest coverage ratio: 14.166666666666668
COGS to revenue (%): 53.57089607872372
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.7136844739992654
Rule of 40 score: -3.7136844739992654
Financial ratios for HBM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.18
Shares outstanding: 443990201
Market cap (USD): 3187849643.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HBM — annual report dated 2022-12-31
Total revenue: 1074588235.2941175
Gross profit: 203594117.6470588
Operating income: 222848529.41176468
Net income: 51751470.58823529
Capital expenditures: 224161029.41176468
Operating cash flow: 358678676.4705882
Depreciation & amortization: 249311029.41176468
Net tangible assets: 1152236764.7058823
Owner earnings: 76901470.58823532
Return on net tangible assets (%): 6.67410318293958
Capex to operating income (%): 100.58896507123674
Buffett classification: The Gruesome
Stock price: 5.04
P/E ratio: 43.239556047489415
Shares outstanding: 443990201
Book value: 1155741911.7647057
P/B ratio: 1.9361680927736133
Market cap (USD): 2237710613.04
Debt to equity: 0.7921961256106819
Current ratio: 1.1709695362640653
Quick ratio: 0.8246877562007563
Effective tax rate (%): 26.543860564629757
Interest coverage ratio: 3.175511572594587
COGS to revenue (%): 81.05375520035034
SG&A to revenue (%): 2.3255145609809507
Free cash flow (dilution-adjusted): 129984558.8235294
Buyback yield (%): 0
Retained earnings: -173163970.5882353
Inventory turnover: 7.641679353856475
Receivables turnover: 11.946213266849224
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.814617553688527
FCF margin (%): 12.096220166411213
Rule of 40 score: 12.096220166411213
Financial ratios for HBM — annual report dated 2023-12-31
Total revenue: 1280303030.3030303
Gross profit: 297348484.8484848
Operating income: 227424242.4242424
Net income: 52651515.15151515
Capital expenditures: 212348484.84848484
Operating cash flow: 361287878.78787875
Depreciation & amortization: 297803030.3030303
Net tangible assets: 1528409090.9090908
Owner earnings: 138106060.6060606
Return on net tangible assets (%): 9.035935563816604
Capex to operating income (%): 93.37108594270487
Buffett classification: The Gruesome
Stock price: 5.5
P/E ratio: 46.37940804690648
Shares outstanding: 443990201
Book value: 1671818181.8181815
P/B ratio: 1.4606529179173466
Market cap (USD): 2441946105.5
Debt to equity: 0.6243429400036252
Current ratio: 1.2526981764049125
Quick ratio: 0.8669519910681058
Effective tax rate (%): 54.21607378129117
Interest coverage ratio: 2.8347497639282344
COGS to revenue (%): 76.77514792899409
SG&A to revenue (%): 2.319526627218935
Free cash flow (dilution-adjusted): 142727272.72727272
Buyback yield (%): 0
Retained earnings: -131515151.51515152
Inventory turnover: 6.25904486251809
Receivables turnover: 8.215848322800195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.286647679678338
FCF margin (%): 11.14792899408284
Revenue growth (%): 19.143592703916784
Rule of 40 score: 30.291521697999624
Financial ratios for HBM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.18
Shares outstanding: 443990201
Market cap (USD): 4075830045.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HBM — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 69930.06993006993
Buffett classification: The Gruesome
Stock price: 8.09
Shares outstanding: 443990201
Market cap (USD): 3591880726.09
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HBM — annual report dated 2024-12-31
Total revenue: 1413426573.4265735
Gross profit: 387272727.2727273
Operating income: 292307692.30769235
Net income: 53636363.63636364
Capital expenditures: 242727272.72727275
Operating cash flow: 465874125.8741259
Depreciation & amortization: 299300699.3006993
Net tangible assets: 1733216783.2167833
Owner earnings: 110209790.20979017
Return on net tangible assets (%): 6.358684688319545
Capex to operating income (%): 83.03827751196172
Buffett classification: The Gruesome
Stock price: 8.09
P/E ratio: 66.96726777455932
Shares outstanding: 443990201
Book value: 1851328671.3286715
P/B ratio: 1.9401637222590844
Market cap (USD): 3591880726.09
Debt to equity: 0.44658910629296666
Current ratio: 1.9517870439314968
Quick ratio: 1.5843261355174982
Effective tax rate (%): 73.05246422893482
Interest coverage ratio: 4.150943396226415
COGS to revenue (%): 72.60043538491985
SG&A to revenue (%): 2.8201068672075995
Free cash flow (dilution-adjusted): 208391608.3916084
Buyback yield (%): 0
Retained earnings: -71608391.60839161
Inventory turnover: 7.433637284701115
Receivables turnover: 8.542688081149619
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.443762120232709
FCF margin (%): 14.743716603997626
Revenue growth (%): 10.397815202548943
Rule of 40 score: 25.141531806546567
Financial ratios for HBM — quarterly report dated 2025-03-31
Total revenue: 416013986.01398605
Gross profit: 161748251.74825177
Operating income: 127412587.41258742
Net income: 70209790.20979021
Capital expenditures: 63846153.84615385
Operating cash flow: 87272727.27272728
Depreciation & amortization: 75874125.87412588
Net tangible assets: 1802447552.4475524
Owner earnings: 82237762.23776224
Return on net tangible assets (%): 4.562560620756547
Capex to operating income (%): 50.10976948408342
Buffett classification: The Good
Stock price: 7.59
P/E ratio: 11.999343736538096
Shares outstanding: 443990201
Book value: 1920489510.4895105
P/B ratio: 1.7547013962763356
Market cap (USD): 3369885625.59
Debt to equity: 0.4311983395841678
Current ratio: 2.3157315731573154
Quick ratio: 1.9161716171617156
Effective tax rate (%): 42.08990075890251
Interest coverage ratio: 7.8534482758620685
COGS to revenue (%): 61.11951588502269
SG&A to revenue (%): 2.3029080517734073
Free cash flow (dilution-adjusted): 19440559.440559443
Buyback yield (%): 0
Retained earnings: -3356643.356643357
Inventory turnover: 2.002202643171806
Receivables turnover: 2.196013289036545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.606135576447303
FCF margin (%): 4.673054294839469
Rule of 40 score: 4.673054294839469
Financial ratios for HBM — quarterly report dated 2025-06-30
Total revenue: 391532846.71532845
Gross profit: 128832116.78832115
Operating income: 110802919.7080292
Net income: 85912408.75912409
Capital expenditures: 88832116.78832117
Operating cash flow: 189708029.19708028
Depreciation & amortization: 70656934.30656934
Net tangible assets: 2031386861.3138685
Owner earnings: 67737226.27737227
Return on net tangible assets (%): 3.334531081566655
Capex to operating income (%): 80.17127799736495
Buffett classification: The Gruesome
Stock price: 10.6
P/E ratio: 30.144951593572394
Shares outstanding: 443990201
Book value: 2090000000
P/B ratio: 2.251816330430622
Market cap (USD): 4706296130.599999
Debt to equity: 0.3969894876541054
Current ratio: 1.0264691358024691
Quick ratio: 0.8642962962962962
Effective tax rate (%): 25.081645983017637
Interest coverage ratio: 6.571428571428571
COGS to revenue (%): 67.09545115585384
SG&A to revenue (%): 3.859060402684564
Free cash flow (dilution-adjusted): 92408759.12408759
Buyback yield (%): 0
Retained earnings: 82408759.12408759
Inventory turnover: 2.19183922046285
Receivables turnover: 2.253781512605042
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.288490284005979
FCF margin (%): 23.60178970917226
Revenue growth (%): -5.884691409830284
Rule of 40 score: 17.717098299341977
Financial ratios for HBM — quarterly report dated 2025-09-30
Total revenue: 249496402.87769786
Gross profit: 46978417.26618706
Operating income: 7482014.388489209
Net income: 160000000
Capital expenditures: 79424460.43165468
Operating cash flow: 81654676.2589928
Depreciation & amortization: 59712230.215827346
Net tangible assets: 2159712230.2158275
Owner earnings: 140287769.78417265
Return on net tangible assets (%): 6.495669553630911
Capex to operating income (%): 1061.5384615384614
Buffett classification: The Gruesome
Stock price: 15.15
P/E ratio: 21.278010741066126
Shares outstanding: 443990201
Book value: 2216187050.3597126
P/B ratio: 3.0351461281475407
Market cap (USD): 6726451545.150001
Debt to equity: 0.35974679435156626
Current ratio: 0.9662779397473275
Quick ratio: 0.7605442176870748
Effective tax rate (%): 32.708018154311645
Interest coverage ratio: 0.46846846846846846
COGS to revenue (%): 81.17070357554788
SG&A to revenue (%): 9.054209919261822
Free cash flow (dilution-adjusted): -12374100.719424462
Buyback yield (%): 0
Retained earnings: 239208633.0935252
Inventory turnover: 1.329711856400567
Receivables turnover: 2.144712430426716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.21277466344776794
FCF margin (%): -4.959630911188005
Revenue growth (%): -36.277018653533545
Rule of 40 score: -41.23664956472155
Financial ratios for HBM — quarterly report dated 2025-12-31
Total revenue: 534963503.649635
Gross profit: 197153284.67153284
Operating income: 158540145.98540145
Net income: 93430656.93430656
Capital expenditures: 104598540.1459854
Operating cash flow: 152846715.32846713
Depreciation & amortization: 111605839.41605839
Net tangible assets: 2300218978.1021895
Owner earnings: 100437956.20437956
Return on net tangible assets (%): 4.3664519404690125
Capex to operating income (%): 65.97605893186004
Buffett classification: The Good
Stock price: 19.84
P/E ratio: 21.508250915289796
Shares outstanding: 443990201
Book value: 2358394160.5839415
P/B ratio: 3.7350692836090373
Market cap (USD): 8808765587.84
Debt to equity: 0.32949551222531726
Current ratio: 0.9466102384634165
Quick ratio: 0.7844876698950108
Effective tax rate (%): 50.213924542979385
Interest coverage ratio: 10.009216589861751
COGS to revenue (%): 63.146404693682626
SG&A to revenue (%): 3.943239186792195
Free cash flow (dilution-adjusted): 28905109.489051092
Buyback yield (%): 0
Retained earnings: 336131386.8613138
Inventory turnover: 2.323293172690763
Receivables turnover: 1.9337730870712402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.348696592319706
FCF margin (%): 5.403192795742939
Revenue growth (%): 114.41732124365416
Rule of 40 score: 119.8205140393971
Financial ratios for HBM — annual report dated 2025-12-31
Total revenue: 1613868613.138686
Gross profit: 542481751.8248174
Operating income: 409927007.29927003
Net income: 414963503.649635
Capital expenditures: 340656934.30656934
Operating cash flow: 516277372.2627737
Depreciation & amortization: 322043795.6204379
Net tangible assets: 2300218978.1021895
Owner earnings: 396350364.9635036
Return on net tangible assets (%): 17.230984038333386
Capex to operating income (%): 83.10185185185186
Buffett classification: The Gruesome
Stock price: 19.84
P/E ratio: 21.22780801291258
Shares outstanding: 443990201
Book value: 2358394160.5839415
P/B ratio: 3.7350692836090373
Market cap (USD): 8808765587.84
Debt to equity: 0.32949551222531726
Current ratio: 0.9466102384634165
Quick ratio: 0.7844876698950108
Effective tax rate (%): 38.125
Interest coverage ratio: 6.267857142857143
COGS to revenue (%): 66.38625056535504
SG&A to revenue (%): 4.283129805517865
Free cash flow (dilution-adjusted): 128832116.78832115
Buyback yield (%): 0
Retained earnings: 336131386.8613138
Inventory turnover: 7.36847389558233
Receivables turnover: 5.83377308707124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.244143675169182
FCF margin (%): 7.982813206693804
Revenue growth (%): 14.18128422661393
Rule of 40 score: 22.16409743330773
Financial ratios for HCL.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.011363636363637
Shares outstanding: 670712403
Market cap (USD): 3361183746.852273
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCL.DE — annual report dated 2022-12-31
Total revenue: 718905000
Gross profit: 116156000
Operating income: 20469000
Net income: -37348000
Capital expenditures: 149378000
Operating cash flow: 89890000
Depreciation & amortization: 145147000
Net tangible assets: 1978967000
Owner earnings: -41579000
Return on net tangible assets (%): -2.1010456465418574
Capex to operating income (%): 729.7767355513215
Buffett classification: The Gruesome
Stock price: 5.553191489361702
Shares outstanding: 670712403
Book value: 1978967000
P/B ratio: 1.8820902057229536
Market cap (USD): 3724594408.1489363
Debt to equity: 0.266414245411874
Current ratio: 1.5001568926294084
Quick ratio: 0.9920937321394552
Interest coverage ratio: 0.4783258944219849
COGS to revenue (%): 83.84264958513295
SG&A to revenue (%): 6.034733379236477
Free cash flow (dilution-adjusted): -65500000
Buyback yield (%): 0
Retained earnings: -403931000
Inventory turnover: 6.647575877889536
Receivables turnover: 12.874142655038412
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7446776774234858
FCF margin (%): -9.111078654342368
Rule of 40 score: -9.111078654342368
Financial ratios for HCL.DE — annual report dated 2023-12-31
Total revenue: 720227000
Gross profit: 112949000
Operating income: 39153000
Net income: -84217000
Capital expenditures: 223887000
Operating cash flow: 75499000
Depreciation & amortization: 163672000
Net tangible assets: 1968104000
Owner earnings: -144432000
Return on net tangible assets (%): -7.3386365761158965
Capex to operating income (%): 571.8259137230864
Buffett classification: The Gruesome
Stock price: 4.877777777777777
Shares outstanding: 670712403
Book value: 1968104000
P/B ratio: 1.6623034426195633
Market cap (USD): 3271586054.633333
Debt to equity: 0.3367784426026267
Current ratio: 1.652876921122825
Quick ratio: 1.0581417502857868
Interest coverage ratio: 0.9038297282947436
COGS to revenue (%): 84.31758320640576
SG&A to revenue (%): 5.931740965001312
Free cash flow (dilution-adjusted): -154986000
Buyback yield (%): 0
Retained earnings: -503861000
Inventory turnover: 6.484756585902378
Receivables turnover: 21.748610943350645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3720351942989384
FCF margin (%): -21.5190488554303
Revenue growth (%): 0.18389077833649786
Rule of 40 score: -21.3351580770938
Financial ratios for HCL.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.633333333333333
Shares outstanding: 670712403
Market cap (USD): 4449058939.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCL.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.979166666666667
Shares outstanding: 670712403
Market cap (USD): 3339588839.9375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCL.DE — annual report dated 2024-12-31
Total revenue: 929925000
Gross profit: 198210000
Operating income: 171000000
Net income: 35802000
Capital expenditures: 214492000
Operating cash flow: 218277000
Depreciation & amortization: 190471000
Net tangible assets: 2039514000
Owner earnings: 11781000
Return on net tangible assets (%): 0.5776376136667853
Capex to operating income (%): 125.43391812865497
Buffett classification: The Gruesome
Stock price: 4.979166666666667
P/E ratio: 93.27939332823586
Shares outstanding: 670712403
Book value: 2039514000
P/B ratio: 1.6374434497323875
Market cap (USD): 3339588839.9375
Debt to equity: 0.27002168163591916
Current ratio: 1.0824614078185182
Quick ratio: 0.5520476349336325
Effective tax rate (%): 45.93149691917361
Interest coverage ratio: 3.43139222217763
COGS to revenue (%): 78.68537785305266
SG&A to revenue (%): 4.882651826760222
Free cash flow (dilution-adjusted): -4874000
Buyback yield (%): 0
Retained earnings: -493529000
Inventory turnover: 6.9729644735838985
Receivables turnover: 18.957556112775976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.143958333183627
FCF margin (%): -0.5241282899158534
Revenue growth (%): 29.115542738608802
Rule of 40 score: 28.591414448692948
Financial ratios for HCL.DE — quarterly report dated 2025-03-31
Total revenue: 205334000
Gross profit: 68681000
Operating income: 51501000
Net income: 28872000
Capital expenditures: 37838000
Operating cash flow: 35738000
Depreciation & amortization: 30603000
Net tangible assets: 2073967000
Owner earnings: 21637000
Return on net tangible assets (%): 1.0432663586257642
Capex to operating income (%): 73.47041805013494
Buffett classification: The Good
Stock price: 5.521739130434782
P/E ratio: 32.068257489202715
Shares outstanding: 670712403
Book value: 2073967000
P/B ratio: 1.7857077383164934
Market cap (USD): 3703498920.913043
Debt to equity: 0.27418613700217986
Current ratio: 1.4260579077482443
Quick ratio: 0.7464900447537386
Effective tax rate (%): 39.11596958174905
Interest coverage ratio: 4.520804073033708
COGS to revenue (%): 66.55156963776092
SG&A to revenue (%): 5.84364985827968
Free cash flow (dilution-adjusted): -4036000
Buyback yield (%): 0
Retained earnings: -467168000
Inventory turnover: 1.1642229738364416
Receivables turnover: 2.5644631505326654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8065239856126312
FCF margin (%): -1.9655780338375524
Rule of 40 score: -1.9655780338375524
Financial ratios for HCL.DE — quarterly report dated 2025-06-30
Total revenue: 304027000
Gross profit: 119524000
Operating income: 98765000
Net income: 57705000
Capital expenditures: 74300000
Operating cash flow: 161796000
Depreciation & amortization: 46483000
Net tangible assets: 2310033000
Owner earnings: 29888000
Return on net tangible assets (%): 1.2938343305052353
Capex to operating income (%): 75.22907912722118
Buffett classification: The Gruesome
Stock price: 5.905882352941176
P/E ratio: 45.75289678293854
Shares outstanding: 670712403
Book value: 2310033000
P/B ratio: 1.71475842326775
Market cap (USD): 3961148544.77647
Debt to equity: 0.2444649059125995
Current ratio: 2.6681937376270977
Quick ratio: 1.9900964956830878
Effective tax rate (%): 36.07227527529746
Interest coverage ratio: 8.898549418866564
COGS to revenue (%): 60.68638640647048
SG&A to revenue (%): 4.12463366740454
Free cash flow (dilution-adjusted): 84509000
Buyback yield (%): 0.02234200485026095
Retained earnings: -411975000
Inventory turnover: 1.4100667191452612
Receivables turnover: 4.79621069901718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.169208761539382
FCF margin (%): 27.796544385860468
Revenue growth (%): 48.06461667332249
Rule of 40 score: 75.86116105918296
Financial ratios for HCL.DE — quarterly report dated 2025-09-30
Total revenue: 409542000
Gross profit: 180467000
Operating income: 153170000
Net income: 100726000
Capital expenditures: 57905000
Operating cash flow: 148049000
Depreciation & amortization: 49377000
Net tangible assets: 2449644000
Owner earnings: 92198000
Return on net tangible assets (%): 3.763730566563958
Capex to operating income (%): 37.80440033949207
Buffett classification: The Good
Stock price: 11.988235294117647
P/E ratio: 42.92861353981014
Shares outstanding: 670712403
Book value: 2449644000
P/B ratio: 3.2823782157109602
Market cap (USD): 8040658101.847059
Debt to equity: 0.11338218941201252
Current ratio: 2.153175529254876
Quick ratio: 1.5145357559593267
Effective tax rate (%): 35.26731489752768
Interest coverage ratio: 11.42633345766505
COGS to revenue (%): 55.934434075137595
SG&A to revenue (%): 3.3871983825834713
Free cash flow (dilution-adjusted): 87505000
Buyback yield (%): 0
Retained earnings: -313902000
Inventory turnover: 1.9930657061321082
Receivables turnover: 3.3223168654173767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.035386104346271
FCF margin (%): 21.366550927621585
Revenue growth (%): 34.70579915599601
Rule of 40 score: 56.07235008361759
Financial ratios for HCL.DE — quarterly report dated 2025-12-31
Total revenue: 448111000
Gross profit: 248208000
Operating income: 228281000
Net income: 134409000
Capital expenditures: 82346000
Operating cash flow: 217055000
Depreciation & amortization: 39107000
Net tangible assets: 2591646000
Owner earnings: 91170000
Return on net tangible assets (%): 3.5178415570645063
Capex to operating income (%): 36.0722092508794
Buffett classification: The Good
Stock price: 19.858823529411765
P/E ratio: 41.40212130776815
Shares outstanding: 670712403
Book value: 2591646000
P/B ratio: 5.139420758145482
Market cap (USD): 13319559250.164705
Debt to equity: 0.10641885504424602
Current ratio: 2.717797239640013
Quick ratio: 2.2221027448135287
Effective tax rate (%): 28.617102069646773
Interest coverage ratio: 41.31035106768006
COGS to revenue (%): 44.61015239527706
SG&A to revenue (%): 4.288000071410878
Free cash flow (dilution-adjusted): 131353000
Buyback yield (%): 0
Retained earnings: -182143000
Inventory turnover: 1.741542884523239
Receivables turnover: 2.391966478061279
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.8571777015939235
FCF margin (%): 29.312603350509136
Revenue growth (%): 9.417593311552904
Rule of 40 score: 38.73019666206204
Financial ratios for HCL.DE — annual report dated 2025-12-31
Total revenue: 1423019000
Gross profit: 622203000
Operating income: 536667000
Net income: 321712000
Capital expenditures: 252389000
Operating cash flow: 562638000
Depreciation & amortization: 165570000
Net tangible assets: 2591646000
Owner earnings: 234893000
Return on net tangible assets (%): 9.0634677729906
Capex to operating income (%): 47.0289770006354
Buffett classification: The Good
Stock price: 19.858823529411765
P/E ratio: 41.40212130776815
Shares outstanding: 670712403
Book value: 2591646000
P/B ratio: 5.139420758145482
Market cap (USD): 13319559250.164705
Debt to equity: 0.10641885504424602
Current ratio: 2.717797239640013
Quick ratio: 2.2221027448135287
Effective tax rate (%): 32.861832425878426
Interest coverage ratio: 12.90654385416416
COGS to revenue (%): 56.27584733584021
SG&A to revenue (%): 4.0495594226078495
Free cash flow (dilution-adjusted): 299331000
Buyback yield (%): 0
Retained earnings: -182143000
Inventory turnover: 6.976660713507862
Receivables turnover: 7.595916515426497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.12057501754989
FCF margin (%): 21.034926448627882
Revenue growth (%): 53.02513643573407
Rule of 40 score: 74.06006288436195
Financial ratios for HEALTHX.NS — annual report dated 2022-03-31
Total revenue: 83054147.4350521
Gross profit: 5872992.219438218
Operating income: -6943993.142555716
Net income: 114085744.42832652
Capital expenditures: 617789.7929579322
Operating cash flow: -27318370.03824344
Depreciation & amortization: 548094.4217328235
Net tangible assets: 104212475.2736384
Owner earnings: 114016049.05710141
Return on net tangible assets (%): 109.40729385586616
Buffett classification: The Gruesome
Stock price: 4.722405380456284
P/E ratio: 1.3167471282915675
Shares outstanding: 31810500
Book value: 144300250.5604642
P/B ratio: 1.0410382225362742
Market cap (USD): 150222076.35500464
Debt to equity: 0.0016937956668660154
Current ratio: 6.188292724998922
Quick ratio: 4.229890034067877
Effective tax rate (%): 22.025702403225715
Interest coverage ratio: -32.507902210149396
COGS to revenue (%): 92.92871891312727
R&D to revenue (%): 0
SG&A to revenue (%): 1.4428399128865752
Free cash flow (dilution-adjusted): -27942146.907556377
Buyback yield (%): 0
Retained earnings: 68924673.6120269
Inventory turnover: 5.154995662073309
Receivables turnover: 29.710050853374344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.3167132567250075
FCF margin (%): -33.64328907163485
Rule of 40 score: -33.64328907163485
Financial ratios for HEALTHX.NS — annual report dated 2023-03-31
Total revenue: 126454092.57003655
Gross profit: 8666735.68818514
Operating income: -6265030.450669915
Net income: -8795432.39951279
Capital expenditures: 1972423.8733252133
Operating cash flow: -13638063.337393424
Depreciation & amortization: 998477.4665042631
Net tangible assets: 87351741.77831914
Owner earnings: -9769378.806333741
Return on net tangible assets (%): -11.183954214818552
Buffett classification: The Gruesome
Stock price: 2.6863580998781975
Shares outstanding: 31810500
Book value: 121018806.33373934
P/B ratio: 0.7061249150029933
Market cap (USD): 85454394.3361754
Debt to equity: 0.009385601980103154
Current ratio: 5.452075838992402
Quick ratio: 3.4243224816771773
Interest coverage ratio: -59.28526970954357
COGS to revenue (%): 93.14633831769021
R&D to revenue (%): 0.0017048933618098688
SG&A to revenue (%): 0.4464701531446951
Free cash flow (dilution-adjusted): -16011668.696711328
Buyback yield (%): 0
Retained earnings: 54741059.683313034
Inventory turnover: 5.347699906764186
Receivables turnover: 29.592594070581793
Capitalized R&D asset: 2155.9074299634594
ROCI (R&D-adjusted, %): -4.605161704228907
FCF margin (%): -12.662040722678288
Revenue growth (%): 52.25500047294204
Rule of 40 score: 39.592959750263745
Financial ratios for HEALTHX.NS — annual report dated 2024-03-31
Total revenue: 162617903.8253987
Gross profit: 14384518.527401367
Operating income: -2753903.3457249072
Net income: 1065199.6642283248
Capital expenditures: 1630795.0593596355
Operating cash flow: 4300863.412879242
Depreciation & amortization: 1095802.8540592396
Net tangible assets: 87081844.34584482
Owner earnings: 530207.4589279292
Return on net tangible assets (%): 0.6088610811022958
Buffett classification: The Gruesome
Stock price: 3.644433781190019
P/E ratio: 108.83523971116774
Shares outstanding: 31810500
Book value: 119862597.43374506
P/B ratio: 0.9672013061507946
Market cap (USD): 115931260.7965451
Debt to equity: 0.003884609451082314
Current ratio: 7.961515728905778
Quick ratio: 6.39895230589861
Interest coverage ratio: -22.755449861276258
COGS to revenue (%): 91.15440662496432
R&D to revenue (%): 0
SG&A to revenue (%): 0.49314537951450466
Free cash flow (dilution-adjusted): 2594255.905983931
Buyback yield (%): 0
Retained earnings: 54861470.20026382
Inventory turnover: 10.675084438234219
Receivables turnover: 38.97370848841052
Capitalized R&D asset: 1444.457978075518
ROCI (R&D-adjusted, %): -2.1358256207061816
Rosenberg metric: 2652.146729376566
FCF margin (%): 1.595307678279606
Revenue growth (%): 28.59837156739934
Rule of 40 score: 30.193679245678947
Financial ratios for HEALTHX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 77939022.93358815
Buffett classification: The Gruesome
Stock price: 3.569039655996178
Shares outstanding: 31810500
Book value: 106550776.39751554
P/B ratio: 1.0655289413706581
Market cap (USD): 113532935.97706641
Debt to equity: 0.0012631676653291754
Current ratio: 3.0874135441072283
Quick ratio: 1.1565836943778531
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEALTHX.NS — quarterly report dated 2024-12-31
Total revenue: 32651626.06364378
Gross profit: 1991117.8459027857
Operating income: -3065765.2407040447
Net income: -3139724.9096631305
Capital expenditures: 0
Depreciation & amortization: 166814.31402261334
Owner earnings: -2972910.5956405173
Buffett classification: The Gruesome
Stock price: 3.69332089987178
Shares outstanding: 31810500
Market cap (USD): 117486384.48537126
Interest coverage ratio: -524.9740518962076
COGS to revenue (%): 93.90193357592132
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEALTHX.NS — annual report dated 2025-03-31
Total revenue: 127370890.81131634
Gross profit: 8431201.776946457
Operating income: -9735702.595277064
Net income: -10657832.592938974
Capital expenditures: 1177379.0039747485
Operating cash flow: -2023451.0170680382
Depreciation & amortization: 681412.2048164601
Net tangible assets: 74076268.41243862
Owner earnings: -11153799.392097263
Return on net tangible assets (%): -15.057183131844095
Buffett classification: The Gruesome
Stock price: 2.8290348932197453
Shares outstanding: 31810500
Book value: 101067909.74982463
P/B ratio: 0.8904212493711225
Market cap (USD): 89993014.47076671
Debt to equity: 0.001062999307488917
Current ratio: 5.913221437345184
Quick ratio: 4.787994441927942
Interest coverage ratio: -383.4217311233886
COGS to revenue (%): 93.38058976957599
SG&A to revenue (%): 0.7885414140731798
Free cash flow (dilution-adjusted): -3234182.8384381575
Buyback yield (%): 0
Retained earnings: 42769768.529342994
Inventory turnover: 9.224502988821726
Receivables turnover: 109.2173660257824
Capitalized R&D asset: 711.4494518879417
ROCI (R&D-adjusted, %): -9.503577084894276
FCF margin (%): -2.5391852234347523
Revenue growth (%): -21.674743177065395
Rule of 40 score: -24.213928400500148
Financial ratios for HEALTHX.NS — quarterly report dated 2025-03-31
Total revenue: 32982137.011924244
Gross profit: 1967933.130699088
Operating income: -3535223.2873509466
Net income: 2054255.319148936
Capital expenditures: 0
Depreciation & amortization: 156277.7647884031
Net tangible assets: 74076268.41243862
Owner earnings: 2210533.083937339
Return on net tangible assets (%): 2.9841312627002607
Buffett classification: The Gruesome
Stock price: 2.8290348932197453
P/E ratio: 10.952024029326866
Shares outstanding: 31810500
Book value: 101067909.74982463
P/B ratio: 0.8904212493711225
Market cap (USD): 89993014.47076671
Debt to equity: 0.001062999307488917
Current ratio: 5.913221437345184
Quick ratio: 4.787994441927942
Interest coverage ratio: -2326.1769230769232
COGS to revenue (%): 94.03333649973132
Buyback yield (%): 0
Retained earnings: 42769768.529342994
Inventory turnover: 2.4053418898347423
Receivables turnover: 28.28136089336194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.450703244975363
Revenue growth (%): 1.0122342686279717
Rule of 40 score: 1.0122342686279717
Financial ratios for HEALTHX.NS — quarterly report dated 2025-06-30
Total revenue: 32616510.648256496
Gross profit: 2474210.1567985024
Operating income: -1731418.2073484673
Net income: 3111642.8738591154
Capital expenditures: 0
Depreciation & amortization: 136707.2314533115
Owner earnings: 3248350.105312427
Buffett classification: The Gruesome
Stock price: 3.474139948513925
P/E ratio: 54.54327610605903
Shares outstanding: 31810500
Market cap (USD): 110514128.83220221
Effective tax rate (%): 11.907601386045464
Interest coverage ratio: -172.0546511627907
COGS to revenue (%): 92.41424018810315
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.1085587435876627
Rule of 40 score: -1.1085587435876627
Financial ratios for HEALTHX.NS — quarterly report dated 2025-09-30
Total revenue: 34837181.51071026
Gross profit: 2706629.08680947
Operating income: -1833269.447576099
Net income: -1431138.6696730552
Capital expenditures: 0
Depreciation & amortization: 149413.75422773394
Net tangible assets: 72684069.89853439
Owner earnings: -1281724.9154453212
Return on net tangible assets (%): -1.7634192983890216
Buffett classification: The Gruesome
Stock price: 3.4391206313416007
P/E ratio: 183.85509738366437
Shares outstanding: 31810500
Book value: 98789064.2615558
P/B ratio: 1.1074115101813504
Market cap (USD): 109400146.84329198
Debt to equity: 0.005875660050281937
Current ratio: 2.127913365408808
Quick ratio: 0.6666850664188262
Interest coverage ratio: -429.0527704485488
COGS to revenue (%): 92.2306312697043
Buyback yield (%): 0
Inventory turnover: 2.5037358636763356
Receivables turnover: 28.60370267518282
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7482972725719637
Revenue growth (%): 6.808425605062298
Rule of 40 score: 6.808425605062298
Financial ratios for HEALTHX.NS — quarterly report dated 2025-12-31
Total revenue: 38043589.172329284
Gross profit: 2930099.142252423
Operating income: -1865623.2594407932
Net income: 125843.82310348669
Capital expenditures: 0
Depreciation & amortization: 241561.76896513312
Owner earnings: 367405.5920686198
Buffett classification: The Gruesome
Stock price: 3.2872897404478114
P/E ratio: 27.086525318635555
Shares outstanding: 31810500
Market cap (USD): 104570330.2885151
Effective tax rate (%): 59.8672036573419
Interest coverage ratio: -98.74823113207547
COGS to revenue (%): 92.29804756596518
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 9.203981271083173
Rule of 40 score: 9.203981271083173
Financial ratios for HLS.TO — annual report dated 2021-12-31
Operating income: -4948031.496062992
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.11811023622047244
Shares outstanding: 31274931
Market cap (USD): 3693889.4881889764
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HLS.TO — annual report dated 2022-12-31
Total revenue: 45196323.52941176
Gross profit: 41533823.52941176
Operating income: -9924264.705882352
Net income: -17351470.588235293
Capital expenditures: 33088.23529411764
Operating cash flow: 12457352.94117647
Depreciation & amortization: 25295588.235294115
Net tangible assets: -51250000
Owner earnings: 7911029.411764705
Buffett classification: The Gruesome
Stock price: 0.07352941176470588
Shares outstanding: 31274931
Book value: 92145588.23529412
P/B ratio: 0.024956455577012083
Market cap (USD): 2299627.279411765
Debt to equity: 0.7767838618554397
Current ratio: 1.4226995831997435
Quick ratio: 1.1372875921769796
Interest coverage ratio: -1.844608446084461
COGS to revenue (%): 8.103535230286168
SG&A to revenue (%): 48.56915092651341
Free cash flow (dilution-adjusted): 2847058.823529412
Buyback yield (%): 31.910542024856902
Retained earnings: -109153676.47058822
Inventory turnover: 0.5595371826555829
Receivables turnover: 5.491066642844381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.4130341819425825
FCF margin (%): 6.299315079636228
Rule of 40 score: 6.299315079636228
Financial ratios for HLS.TO — annual report dated 2023-12-31
Total revenue: 47783333.33333333
Gross profit: 42007575.75757576
Operating income: -7840151.515151515
Net income: -20856818.18181818
Capital expenditures: 31060.60606060606
Operating cash flow: 11961363.636363637
Depreciation & amortization: 24196212.12121212
Net tangible assets: -48975000
Owner earnings: 3308333.3333333354
Buffett classification: The Gruesome
Stock price: 0.030303030303030304
Shares outstanding: 31274931
Book value: 74012878.78787878
P/B ratio: 0.012804868522063115
Market cap (USD): 947725.1818181819
Debt to equity: 0.8968647962578176
Current ratio: 1.6522407074340528
Quick ratio: 1.2950014988009593
Interest coverage ratio: -1.183013260173754
COGS to revenue (%): 12.087389415607065
SG&A to revenue (%): 44.84573675365444
Free cash flow (dilution-adjusted): 12225757.575757576
Buyback yield (%): 124.06102510665808
Retained earnings: -132921969.69696969
Inventory turnover: 0.7996643591357248
Receivables turnover: 5.898073686179165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.674664970499857
FCF margin (%): 25.58581983067508
Revenue growth (%): 5.7239385903547095
Rule of 40 score: 31.30975842102979
Financial ratios for HLS.TO — quarterly report dated 2024-09-30
Operating income: -3631851.8518518517
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.029629629629629627
Shares outstanding: 31274931
Market cap (USD): 926664.6222222222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HLS.TO — annual report dated 2024-12-31
Total revenue: 39593706.2937063
Gross profit: 33302097.902097903
Operating income: -5374825.174825175
Net income: -13744755.244755246
Capital expenditures: 10489.51048951049
Operating cash flow: 5596503.496503497
Depreciation & amortization: 15886013.986013986
Net tangible assets: -35511188.81118881
Owner earnings: 2130769.23076923
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 31274931
Book value: 49888811.1888112
P/B ratio: 0.017535459833756182
Market cap (USD): 874823.2447552448
Debt to equity: 0.931441947828037
Current ratio: 1.5701929474384566
Quick ratio: 1.168418718119317
Interest coverage ratio: -0.7622731329961321
COGS to revenue (%): 15.890425475547076
SG&A to revenue (%): 47.56000635828962
Free cash flow (dilution-adjusted): 4455244.755244755
Buyback yield (%): 47.96173651030597
Retained earnings: -135790209.7902098
Inventory turnover: 0.9932656215500111
Receivables turnover: 7.524119601328905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.59555617032739
FCF margin (%): 11.252406436002047
Revenue growth (%): -17.13908693329689
Rule of 40 score: -5.886680497294844
Financial ratios for HLS.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 31274931
Market cap (USD): 874823.2447552448
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HLS.TO — quarterly report dated 2025-03-31
Total revenue: 8827272.727272728
Gross profit: 7150349.6503496505
Operating income: -1532167.8321678322
Net income: -3102097.9020979023
Capital expenditures: 14685.314685314686
Operating cash flow: 2477622.3776223776
Depreciation & amortization: 3748251.7482517483
Net tangible assets: -35230069.93006993
Owner earnings: 631468.5314685313
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 31274931
Book value: 46711888.11188812
P/B ratio: 0.023410080391628493
Market cap (USD): 1093529.055944056
Debt to equity: 0.9542501272493188
Current ratio: 1.4290268456375839
Quick ratio: 1.1151426174496646
Interest coverage ratio: -1.0857284440039643
COGS to revenue (%): 18.997068842588924
SG&A to revenue (%): 44.52190446011249
Free cash flow (dilution-adjusted): 2007692.307692308
Buyback yield (%): 11.255020834418467
Retained earnings: -138694405.5944056
Inventory turnover: 0.3204597086729921
Receivables turnover: 1.6177111367422787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6839985550354704
FCF margin (%): 22.744197100530776
Rule of 40 score: 22.744197100530776
Financial ratios for HLS.TO — quarterly report dated 2025-06-30
Total revenue: 10343795.620437955
Gross profit: 8515328.467153285
Operating income: -567883.2116788321
Net income: -2000729.9270072991
Capital expenditures: 63503.64963503649
Operating cash flow: 3360583.941605839
Depreciation & amortization: 4002189.7810218977
Net tangible assets: -36122627.73722628
Owner earnings: 1937956.204379562
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 31274931
Book value: 48583211.678832114
P/B ratio: 0.023494141288180413
Market cap (USD): 1141420.8394160583
Debt to equity: 0.8349434336453373
Current ratio: 1.0886585233245134
Quick ratio: 0.8413498133314002
Interest coverage ratio: -0.44893248701673394
COGS to revenue (%): 17.676945875379296
SG&A to revenue (%): 39.48204078752382
Free cash flow (dilution-adjusted): 2227737.226277372
Buyback yield (%): 53.2695020174465
Retained earnings: -145864233.57664233
Inventory turnover: 0.3671405540085007
Receivables turnover: 1.5662024756852342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6404188240329922
FCF margin (%): 21.53694164138028
Revenue growth (%): 17.179970983334186
Rule of 40 score: 38.71691262471447
Financial ratios for HLS.TO — quarterly report dated 2025-09-30
Total revenue: 9720143.884892087
Gross profit: 7894964.028776979
Operating income: -988489.2086330936
Net income: -2818705.0359712234
Capital expenditures: 46043.165467625906
Operating cash flow: 1781294.964028777
Depreciation & amortization: 3964748.2014388493
Net tangible assets: -34486330.9352518
Owner earnings: 1100000
Buffett classification: The Gruesome
Stock price: 0.04316546762589928
Shares outstanding: 31274931
Book value: 44416546.76258994
P/B ratio: 0.030394011240868813
Market cap (USD): 1349997.0215827338
Debt to equity: 0.8761074847341226
Current ratio: 1.1721521145975444
Quick ratio: 0.8692019099590724
Interest coverage ratio: -0.561963190184049
COGS to revenue (%): 18.777292576419214
SG&A to revenue (%): 41.18866109096292
Free cash flow (dilution-adjusted): 1015827.3381294966
Buyback yield (%): 41.726710763966196
Retained earnings: -145915827.33812952
Inventory turnover: 0.3570222347312131
Receivables turnover: 1.6434740299233672
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.176651937108211
FCF margin (%): 10.450743838353935
Revenue growth (%): -6.029234900132942
Rule of 40 score: 4.421508938220993
Financial ratios for HLS.TO — annual report dated 2025-12-31
Total revenue: 40510948.90510949
Gross profit: 33151094.890510947
Operating income: -2997080.2919708025
Net income: -9072992.700729927
Capital expenditures: 149635.03649635037
Operating cash flow: 12503649.635036495
Depreciation & amortization: 15924817.518248174
Net tangible assets: -32084671.53284671
Owner earnings: 6702189.781021897
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 31274931
Book value: 45014598.540145986
P/B ratio: 0.025356681530728065
Market cap (USD): 1141420.8394160583
Debt to equity: 0.8078806550997242
Current ratio: 1.113816469507293
Quick ratio: 0.802228092339497
Interest coverage ratio: -0.5788805864937262
COGS to revenue (%): 18.16756756756757
SG&A to revenue (%): 39.63603603603603
Free cash flow (dilution-adjusted): 9864963.503649633
Buyback yield (%): 115.04421864272058
Retained earnings: -149016058.39416057
Inventory turnover: 1.2388499815702174
Receivables turnover: 7.059272449758331
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.6855522045095497
FCF margin (%): 24.351351351351347
Revenue growth (%): 2.3166374084787105
Rule of 40 score: 26.66798875983006
Financial ratios for HLS.TO — quarterly report dated 2025-12-31
Total revenue: 11091240.875912407
Gross profit: 9162043.795620438
Operating income: 172992.700729927
Net income: -974452.5547445255
Capital expenditures: 24087.59124087591
Operating cash flow: 4749635.03649635
Depreciation & amortization: 3987591.240875912
Net tangible assets: -32084671.53284671
Owner earnings: 2989051.0948905107
Capex to operating income (%): 13.924050632911392
Buffett classification: The Great
Stock price: 0.0364963503649635
Shares outstanding: 31274931
Book value: 45014598.540145986
P/B ratio: 0.025356681530728065
Market cap (USD): 1141420.8394160583
Debt to equity: 0.8078806550997242
Current ratio: 1.113816469507293
Quick ratio: 0.802228092339497
Interest coverage ratio: 0.26421404682274247
COGS to revenue (%): 17.393879565646593
SG&A to revenue (%): 34.3402435011517
Free cash flow (dilution-adjusted): 4510948.905109488
Buyback yield (%): 0.447642874096189
Retained earnings: -149016058.39416057
Inventory turnover: 0.3247327681533358
Receivables turnover: 1.9327143220554563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.21273158121499353
FCF margin (%): 40.67127344521224
Revenue growth (%): 14.105727314915583
Rule of 40 score: 54.77700076012783
Financial ratios for HVO.L — annual report dated 2021-12-31
Gross profit: 48514864.86486486
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0029729729729729734
Shares outstanding: 688401079
Market cap (USD): 2046597.8024324328
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HVO.L — annual report dated 2022-12-31
Total revenue: 58406024.096385546
Operating income: 7400000
Net income: -934939.7590361446
Capital expenditures: 1536144.5783132531
Operating cash flow: 19254216.86746988
Depreciation & amortization: 3530120.481927711
Net tangible assets: 17102409.63855422
Owner earnings: 1059036.1445783132
Capex to operating income (%): 20.758710517746664
Buffett classification: The Great
Stock price: 0.0012048192771084338
Shares outstanding: 688401079
Book value: 24359036.144578315
P/B ratio: 0.03404892071421506
Market cap (USD): 829398.8903614458
Debt to equity: 0.07730734988623998
Current ratio: 1.4189148328573828
Quick ratio: 1.4021501763816564
Interest coverage ratio: 46.180451127819545
COGS to revenue (%): 0
SG&A to revenue (%): 47.98151700806568
Free cash flow (dilution-adjusted): 17271084.337349396
Buyback yield (%): 0
Retained earnings: 30169879.518072292
Inventory turnover: 0
Receivables turnover: 5.857539874335428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.415452232246118
FCF margin (%): 29.570724260989746
Rule of 40 score: 29.570724260989746
Financial ratios for HVO.L — annual report dated 2023-12-31
Total revenue: 70940506.32911392
Operating income: 13064556.962025316
Net income: 20398734.17721519
Capital expenditures: 6553164.556962025
Operating cash flow: 21821518.987341773
Depreciation & amortization: 3437974.6835443038
Net tangible assets: 36277215.18987342
Owner earnings: 17283544.30379747
Return on net tangible assets (%): 47.64297428382009
Capex to operating income (%): 50.15986822982269
Buffett classification: The Good
Stock price: 0.002911392405063291
P/E ratio: 0.09825147264660256
Shares outstanding: 688401079
Book value: 43450632.91139241
P/B ratio: 0.04612604095146536
Market cap (USD): 2004205.6730379746
Debt to equity: 0.36502942376041475
Current ratio: 1.4782262649232518
Quick ratio: 1.466117111995452
Effective tax rate (%): -44.56804521395891
Interest coverage ratio: 66.58709677419355
COGS to revenue (%): 0
SG&A to revenue (%): 43.12759845118927
Free cash flow (dilution-adjusted): 14540506.329113923
Buyback yield (%): 0
Retained earnings: 48958227.848101266
Inventory turnover: 0
Receivables turnover: 6.147087857847976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.48060273060273
FCF margin (%): 20.49676141534179
Revenue growth (%): 21.460940761937714
Rule of 40 score: 41.9577021772795
Financial ratios for HVO.L — annual report dated 2024-12-31
Total revenue: 78406250
Operating income: 16071250
Net income: 13315000
Capital expenditures: 3020000
Operating cash flow: 12920000
Depreciation & amortization: 4448750
Net tangible assets: 48717500
Owner earnings: 14743750
Return on net tangible assets (%): 30.263765587314623
Capex to operating income (%): 18.791319903554484
Buffett classification: The Great
Stock price: 0.0025
P/E ratio: 0.12925292508449118
Shares outstanding: 688401079
Book value: 55843750
P/B ratio: 0.0308181792501399
Market cap (USD): 1721002.6975
Debt to equity: 0.28877448237269165
Current ratio: 1.8871690427698575
Quick ratio: 1.8619771267429108
Effective tax rate (%): 19.843479569568817
Interest coverage ratio: 13.46282722513089
COGS to revenue (%): 0
SG&A to revenue (%): 41.65484256675966
Free cash flow (dilution-adjusted): 8800000
Buyback yield (%): 0
Retained earnings: 61008750
Inventory turnover: 0
Receivables turnover: 14.041862547571077
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.56484959107024
FCF margin (%): 11.223595057791949
Revenue growth (%): 10.523950359545363
Rule of 40 score: 21.747545417337314
Financial ratios for HVO.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 48717500
Buffett classification: The Gruesome
Stock price: 0.0025
Shares outstanding: 688401079
Book value: 55843750
P/B ratio: 0.0308181792501399
Market cap (USD): 1721002.6975
Debt to equity: 0.28877448237269165
Current ratio: 1.8871690427698575
Quick ratio: 1.8619771267429108
Buyback yield (%): 0
Retained earnings: 61008750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HVO.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 35227397.26027397
Buffett classification: The Gruesome
Stock price: 0.0015068493150684932
Shares outstanding: 688401079
Book value: 59765753.42465753
P/B ratio: 0.017356372754360635
Market cap (USD): 1037316.6943835617
Debt to equity: 0.3370006188544317
Current ratio: 1.597303303077097
Quick ratio: 1.5310534443147152
Buyback yield (%): 0
Retained earnings: 65382191.78082192
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ISRG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 359.3
Shares outstanding: 358278038
Market cap (USD): 128729299053.40001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0